In a patient with an uncomplicated urinary tract infection who has no β‑lactam allergy, normal renal function, and is not pregnant, which oral antibiotic is preferred: amoxicillin‑clavulanate (Augmentin) or cephalexin?

Nitrofurantoin is preferred over both cephalexin and amoxicillin-clavulanate for uncomplicated UTI

For an uncomplicated urinary tract infection in a non-pregnant patient without β-lactam allergy, nitrofurantoin (100 mg twice daily for 5 days) is the first-line choice, not cephalexin or amoxicillin-clavulanate. However, if you must choose between these two β-lactams, amoxicillin-clavulanate (Augmentin) is the better option based on current resistance patterns and guideline recommendations.

Why Nitrofurantoin Comes First

The most recent 2024 guidelines clearly establish the treatment hierarchy 1:

• First-line agents for uncomplicated cystitis include:

  • Fosfomycin trometamol (3g single dose)
  • Nitrofurantoin (100 mg twice daily for 5 days)
  • Pivmecillinam (400 mg three times daily for 3-5 days)

• Alternative/second-line agents include:

  • Cephalosporins like cefadroxil (500 mg twice daily for 3 days) - only if local E. coli resistance is <20%
  • Trimethoprim-sulfamethoxazole
  • β-lactams such as amoxicillin-clavulanate

The 2024 JAMA guidelines emphasize that nitrofurantoin is "a reasonable drug of choice, based on robust evidence of efficacy and its ability to spare use of more systemically active agents for treating other infections" 2. This antimicrobial stewardship principle is critical—reserving broader-spectrum agents helps preserve their effectiveness.

If Choosing Between Cephalexin vs Augmentin

Amoxicillin-clavulanate is superior to cephalexin for empiric UTI treatment for several reasons:

Resistance Patterns Favor Augmentin

Recent data shows concerning resistance trends for cephalexin:

• A 2003 study demonstrated cephalexin resistance increased from 18% to 37% over an 8-year period 3
• The same study showed amoxicillin-clavulanate had only 24% resistance compared to cephalexin's 37% 3
• 95% of organisms remained susceptible to second-generation cephalosporins, but only 63% to cephalexin 3

Spectrum of Activity

Amoxicillin-clavulanate has broader coverage:

• The clavulanic acid component inhibits β-lactamases, including many Ambler class A enzymes 4
• This makes it effective against ESBL-producing organisms in certain contexts 4, 5
• Cephalexin is a first-generation cephalosporin with more limited Gram-negative coverage 6

Guideline Positioning

The 2024 European guidelines list cephalosporins (like cefadroxil) as alternatives only when local E. coli resistance is <20% 1. This conditional recommendation reflects growing resistance concerns. While amoxicillin-clavulanate isn't listed as first-line, it's recognized as a second-line β-lactam option 7, 8.

Important Caveats

When Cephalexin May Be Acceptable

A 2023 study showed 81% clinical success with twice-daily cephalexin for uncomplicated UTI 9. However, this was:

• A single-center study based on local antibiogram data
• Not a comparative trial against other agents
• The 10.6% requiring antibiotic change suggests suboptimal empiric coverage

This doesn't override guideline recommendations—local resistance patterns must guide therapy.

Duration Matters

If using β-lactams 2:

• For cystitis: Insufficient evidence for clear duration recommendation (though 3-7 days is typical)
• For pyelonephritis: 7 days is recommended

Critical Exclusions

Neither agent is appropriate if:

• Patient has risk factors for ESBL-producing organisms (recent antibiotic exposure, healthcare contact)
• Local resistance rates exceed 20% for E. coli
• Patient has complicated UTI or pyelonephritis (requires different approach)
• True β-lactam allergy exists (10% cross-reactivity between penicillins and cephalosporins) 6

Practical Algorithm

1. First, confirm this is truly uncomplicated cystitis (lower tract symptoms, no fever, no flank pain, no complicating factors)

2. Check local antibiogram data:

   • If E. coli resistance to cephalexin >20%: avoid cephalexin
   • If resistance to amoxicillin-clavulanate >20%: consider alternatives

3. Prescribe first-line agent: Nitrofurantoin 100 mg twice daily × 5 days

4. If nitrofurantoin contraindicated (renal impairment with CrCl <30 mL/min, G6PD deficiency):

   • Choose amoxicillin-clavulanate over cephalexin
   • Dose: 500/125 mg three times daily × 3-7 days

5. Reserve cephalexin only if:

   • Local susceptibility data strongly supports it (>80% susceptibility)
   • Patient cannot tolerate other options
   • Dose: 500 mg twice daily × 3-7 days 9

Common Pitfalls to Avoid

• Don't assume all β-lactams are equivalent—resistance patterns differ significantly between cephalexin and amoxicillin-clavulanate
• Don't use fluoroquinolones empirically—reserve for pyelonephritis or when susceptibilities confirm need 7, 8
• Don't forget to counsel about C. difficile risk—all antibiotics carry this risk, though β-lactams have lower rates than fluoroquinolones 6
• Don't ignore pregnancy status—treatment algorithms differ significantly in pregnancy 1